Literature DB >> 11323694

SAP controls T cell responses to virus and terminal differentiation of TH2 cells.

C Wu1, K B Nguyen, G C Pien, N Wang, C Gullo, D Howie, M R Sosa, M J Edwards, P Borrow, A R Satoskar, A H Sharpe, C A Biron, C Terhorst.   

Abstract

SH2D1A, which encodes signaling lymphocyte activation molecule (SLAM)-associated protein (SAP), is altered in patients with X-linked lymphoproliferative disease (XLP), a primary immunodeficiency. SAP-deficient mice infected with lymphocytic choriomeningitis virus had greatly increased numbers of CD8+ and CD4+ interferon-gamma-producing spleen and liver cells compared to wild-type mice. The immune responses of SAP-deficient mice to infection with Leishmania major together with in vitro studies showed that activated SAP-deficient T cells had an impaired ability to differentiate into T helper 2 cells. The aberrant immune responses in SAP-deficient mice show that SAP controls several distinct key T cell signal transduction pathways, which explains in part the complexity of the XLP phenotypes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11323694     DOI: 10.1038/87713

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  83 in total

Review 1.  Genetic approaches to tyrosine kinase signaling pathways in the immune system.

Authors:  Pamela L Schwartzberg
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Defective B cell responses in the absence of SH2D1A.

Authors:  Massimo Morra; Robert A Barrington; Ana C Abadia-Molina; Susumo Okamoto; Aimee Julien; Charles Gullo; Anuj Kalsy; Matthew J Edwards; Gang Chen; Rosanne Spolski; Warren J Leonard; Brigitte T Huber; Persephone Borrow; Christine A Biron; Abhay R Satoskar; Michael C Carroll; Cox Terhorst
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-17       Impact factor: 11.205

3.  SAP modulates B cell functions in a genetic background-dependent manner.

Authors:  Cynthia Detre; Burcu Yigit; Marton Keszei; Wilson Castro; Erica M Magelky; Cox Terhorst
Journal:  Immunol Lett       Date:  2013-06-24       Impact factor: 3.685

Review 4.  X-linked lymphoproliferative disease: genetic lesions and clinical consequences.

Authors:  Andrew J MacGinnitie; Raif Geha
Journal:  Curr Allergy Asthma Rep       Date:  2002-09       Impact factor: 4.806

5.  Induction of epitope-specific neutralizing antibodies against West Nile virus.

Authors:  Theodore Oliphant; Grant E Nybakken; S Kyle Austin; Qing Xu; Jonathan Bramson; Mark Loeb; Mark Throsby; Daved H Fremont; Theodore C Pierson; Michael S Diamond
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

Review 6.  SLAM receptors and SAP influence lymphocyte interactions, development and function.

Authors:  Pamela L Schwartzberg; Kristen L Mueller; Hai Qi; Jennifer L Cannons
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

Review 7.  Target identification and validation in systemic autoimmunity.

Authors:  Stanford L Peng
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

8.  X-linked lymphoproliferative disease in an adult.

Authors:  Takumi Hoshino; Hirokazu Kanegane; Noriko Doki; Hiroyuki Irisawa; Tohru Sakura; Yoshihisa Nojima; Shuichi Miyawaki; Toshio Miyawaki
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

9.  SAP gene transfer restores cellular and humoral immune function in a murine model of X-linked lymphoproliferative disease.

Authors:  Christine Rivat; Claire Booth; Maria Alonso-Ferrero; Michael Blundell; Neil J Sebire; Adrian J Thrasher; H Bobby Gaspar
Journal:  Blood       Date:  2012-12-05       Impact factor: 22.113

Review 10.  X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses.

Authors:  Hamid Bassiri; W C Janice Yeo; Jennifer Rothman; Gary A Koretzky; Kim E Nichols
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.